ArticleJournal of translational internal medicine2026
Alterations in gut microbiota and fecal metabolites in euthyroid autoimmune thyroiditis during early pregnancy.
Article in Journal of translational internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: Euthyroid autoimmune thyroiditis (AIT) during early pregnancy has been linked to adverse pregnancy outcomes, yet the underlying mechanisms remain unclear. This study aimed to investigate the differences in gut microbiota (GM) composition and fecal metabolites between patients with euthyroid AIT and healthy women in the first trimester of pregnancy, and to explore potential associations between them. Methods: A total of 26 pregnant women with euthyroid AIT and 30 healthy pregnant women in their first trimester were enrolled. Gut microbiota profiles were analyzed using 16S rDNA gene sequencing, while fecal metabolomic profiling was performed Results: Significant diferences in GM composition were observed between euthyroid AIT patients and healthy controls. Metabolomic analysis revealed distinct fecal metabolic signatures in euthyroid AIT patients. Kyoto Encyclopedia of Genes and Genomes enrichment analysis indicated that diferential metabolites were mainly involved in arachidonic acid metabolism, alpha-linolenic acid metabolism, serotonergic synapses, and bile secretion pathways. Furthermore, a relationship between specific gut microbes and altered fecal metabolites was identified in the euthyroid AIT group. Conclusions: Pregnant women with euthyroid AIT in the first trimester exhibit distinct alterations in gut microbiota and fecal metabolic profiles, which may contribute to adverse pregnancy outcomes. Elucidating the correlations between GM and fecal metabolites may provide new insights into potential strategies for preventing and managing complications associated with euthyroid AIT in early pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.